Sofosbuvir as a potential alternative to treat the SARS-CoV-2 epidemic

dc.creatorJácome, Rodrigo
dc.creatorCampillo-Balderas, José Alberto
dc.creatorPonce de León, Samuel
dc.creatorBecerra, Arturo
dc.creatorLazcano, Antonio
dc.date.accessioned2020-07-22T00:11:47Z
dc.date.accessioned2022-09-23T18:48:48Z
dc.date.available2020-07-22T00:11:47Z
dc.date.available2022-09-23T18:48:48Z
dc.date.created2020-07-22T00:11:47Z
dc.identifier2045-2322
dc.identifierhttps://www.nature.com/articles/s41598-020-66440-9
dc.identifierhttp://hdl.handle.net/20.500.12010/10918
dc.identifierhttps://doi.org/10.1038/s41598-020-66440-9
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3507851
dc.publisherScience Direct
dc.rightsinfo:eu-repo/semantics/openAccess
dc.sourcereponame:Expeditio Repositorio Institucional UJTL
dc.sourceinstname:Universidad de Bogotá Jorge Tadeo Lozano
dc.subjectSofosbuvir
dc.titleSofosbuvir as a potential alternative to treat the SARS-CoV-2 epidemic


Este ítem pertenece a la siguiente institución